Bookmark
Forward
Explore Literature Results
QuickView for repertaxin (compound)
Most Relevant Literature
- A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared …
- A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast c…
- Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcin…
- Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.
- Multiple anti-tumor effects of Reparixin on thyroid cancer.
